Bio-Rad Laboratories Class BBIO.B
13F holders, Q1 2025 (March 31)5holders −3
0new positions
3sold out
$242.79avg. 13F price*
At the end of Q1 2025, 5 institutions reported holding Bio-Rad Laboratories Class B (BIO.B) in their 13F filings, down 3 from Q4 2024. 0 opened new positions and 3 sold out. The largest holders were CSS LLC ($266K), Morgan Stanley ($172K) and Wells Fargo & Company ($41K).
- Company
- Bio-Rad Laboratories Class B
- CUSIP
- 090572108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $300K |
All 13F filers, Q4 2024 → Q1 2025: 1,174 shares sold, net −1,174 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| CSS LLC | 0.05% | Reduce -18.6% | 1,092 | $266K |
| Morgan Stanley | 0.00% | No change | 712 | $172K |
| Wells Fargo & Company | 0.00% | No change | 170 | $41K |
| Whittier Trust Co. | 0.00% | No change | 160 | $39K |
| UBS Group AG | 0.00% | No change | 1 | $242 |
"% of holder's portfolio" is BIO.B's weight in each manager's 13F, not the share of Bio-Rad Laboratories Class B the manager owns.